Products for Research Use Only
RegisterLogin

NLRP3-IN-2

CAT: 0804-HY-W011082-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W011082-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NLRP3-IN-2, an intermediate substrate in the synthesis of glyburide, inhibits the formation of the NLRP3 inflammasome in cardiomyocytes and limits the infarct size following myocardial ischemia/reperfusion in the mouse, without affecting glucose metabolism[1].
CAS Number
16673-34-0
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
NOD-like Receptor (NLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/nlrp3-in-2.html
Purity
98.00
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(NCCC1=CC=C(S(=O)(N)=O)C=C1)C2=CC(Cl)=CC=C2OC
Molecular Formula
C16H17ClN2O4S
Molecular Weight
368.84
Precautions
H302, H315, H319, H335
References & Citations
[1]Carlo Marchetti, et al. A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse. J Cardiovasc Pharmacol. 2014 Apr;63 (4) :316-322.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NLRP3

Related Products

CatalogName
HY-144223-01NLRP3/AIM2-IN-2
HY-161266COX-2/NLRP3-IN-1
HY-172788NLRP3-IN-78
HY-172102NLRP3-IN-68
HY-171820-01NLRP3-IN-80
HY-170233NLRP3-IN-75
HY-162901NLRP3-IN-48
HY-159719NLRP3-IN-51
HY-156469NLRP3-IN-22
HY-163300NLRP3-IN-30

Alternative Products

CatalogName
A4698-50NLRP3-IN-2
T87015-01NLRP3 antagonist 2
T81667-01NLRP3 agonist 2
T60404-01NLRP3/AIM2-IN-2
QY-E06005Human NLRP3 Inflammasome (NLRP3)
T209071-01COX-2/NLRP3-IN-1
MBS8534011-01NLRP3

Popular Products